Joshua S. Benner

4.4k total citations · 1 hit paper
46 papers, 3.5k citations indexed

About

Joshua S. Benner is a scholar working on Economics and Econometrics, Surgery and Family Practice. According to data from OpenAlex, Joshua S. Benner has authored 46 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 13 papers in Surgery and 11 papers in Family Practice. Recurrent topics in Joshua S. Benner's work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Pharmaceutical Economics and Policy (15 papers) and Lipoproteins and Cardiovascular Health (12 papers). Joshua S. Benner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (23 papers), Pharmaceutical Economics and Policy (15 papers) and Lipoproteins and Cardiovascular Health (12 papers). Joshua S. Benner collaborates with scholars based in United States, United Kingdom and Sweden. Joshua S. Benner's co-authors include Mark McClellan, Daniel B. Smith, John G. Walt, Jason Yeaw, Richard Platt, Allison Petrilla, Mohamed Hussein, Simon Tang, Michael B. Nichol and Richard H. Chapman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Joshua S. Benner

46 papers receiving 3.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Persistence in Use of Statin Therapy in Elderly Patients

2002 1.0k citations Joshua S. Benner profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua S. Benner United States	25	1.2k	1.1k	726	668	546	46	3.5k
Kristijan H. Kahler United States	27	583 0.5×	625 0.5×	309 0.4×	480 0.7×	454 0.8×	72	2.9k
Yea‐Huei Kao Yang Taiwan	31	494 0.4×	154 0.1×	333 0.5×	743 1.1×	1.1k 2.0×	107	4.8k
Alex Z. Fu United States	29	566 0.5×	206 0.2×	312 0.4×	504 0.8×	303 0.6×	117	3.1k
Rhonda L. Bohn United States	28	576 0.5×	574 0.5×	469 0.6×	695 1.0×	729 1.3×	83	3.5k
Yu Ko Taiwan	27	278 0.2×	260 0.2×	446 0.6×	286 0.4×	214 0.4×	86	1.8k
Jeanet W. Blom Netherlands	28	870 0.7×	142 0.1×	703 1.0×	662 1.0×	1.4k 2.5×	102	5.3k
Richard H. Chapman United States	32	1.3k 1.1×	490 0.4×	335 0.5×	528 0.8×	596 1.1×	69	3.9k
Leslie R. Harrold United States	41	776 0.6×	531 0.5×	1.6k 2.2×	818 1.2×	788 1.4×	168	6.9k
Holly M. Holmes United States	35	1.2k 1.0×	491 0.4×	2.4k 3.3×	452 0.7×	394 0.7×	127	4.6k
Colin R. Dormuth Canada	35	1.2k 1.0×	470 0.4×	408 0.6×	763 1.1×	547 1.0×	115	4.3k

Countries citing papers authored by Joshua S. Benner

Since Specialization

Citations

This map shows the geographic impact of Joshua S. Benner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua S. Benner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua S. Benner more than expected).

Fields of papers citing papers by Joshua S. Benner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua S. Benner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua S. Benner. The network helps show where Joshua S. Benner may publish in the future.

Co-authorship network of co-authors of Joshua S. Benner

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua S. Benner. A scholar is included among the top collaborators of Joshua S. Benner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua S. Benner. Joshua S. Benner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McClellan, Mark, Joshua S. Benner, Richard L. Schilsky, et al.. (2011). An accelerated pathway for targeted cancer therapies. Nature Reviews Drug Discovery. 10(2). 79–80. 24 indexed citations

Tunis, Sean, Joshua S. Benner, & Mark McClellan. (2010). Response to comments on ‘Comparative Effectiveness Research’. Statistics in Medicine. 29(19). 1996–1997. 1 indexed citations

Schilsky, Richard L., Jeff Allen, Joshua S. Benner, Ellen V. Sigal, & Mark McClellan. (2010). Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer. The Oncologist. 15(5). 484–487. 17 indexed citations

Platt, Richard, Marcus D. Wilson, K. Arnold Chan, et al.. (2009). The New Sentinel Network — Improving the Evidence of Medical-Product Safety. New England Journal of Medicine. 361(7). 645–647. 168 indexed citations

Yeaw, Jason, et al.. (2009). Comparing Adherence and Persistence Across 6 Chronic Medication Classes. Journal of Managed Care Pharmacy. 15(9). 728–740. 462 indexed citations

Benner, Joshua S., Michael B. Nichol, Eric S. Rovner, et al.. (2009). Patient‐reported reasons for discontinuing overactive bladder medication. British Journal of Urology. 105(9). 1276–1282. 299 indexed citations

Brubaker, Linda, Kristina M. Fanning, Joshua S. Benner, et al.. (2009). Predictors of discontinuing overactive bladder medications. British Journal of Urology. 105(9). 1283–1290. 36 indexed citations

Chapman, Richard H., Allison Petrilla, Lance Berman, Joshua S. Benner, & Simon Tang. (2009). Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?. American Journal of Cardiovascular Drugs. 9(5). 299–308. 5 indexed citations

Amin, Alpesh, Alex C. Spyropoulos, Paul P. Dobesh, et al.. (2009). Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). Journal of Thrombosis and Thrombolysis. 29(3). 326–339. 61 indexed citations

10.

Benner, Joshua S., et al.. (2008). The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients. Value in Health. 12(4). 489–497. 71 indexed citations

11.

Chapman, Richard H., Allison Petrilla, Joshua S. Benner, J. Sanford Schwartz, & Simon Tang. (2008). Predictors of Adherence to Concomitant Antihypertensive and Lipid-Lowering Medications in Older Adults. Drugs & Aging. 25(10). 885–892. 89 indexed citations

12.

Foody, JoAnne M., Amie T. Joyce, Barrett W. Jeffers, Larry Z. Liu, & Joshua S. Benner. (2008). A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease. Diabetes Research and Clinical Practice. 82(1). e13–e15. 1 indexed citations

13.

Benner, Joshua S., Timothy W. Smith, Allison Petrilla, et al.. (2008). Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States. Journal of the American Society of Hypertension. 2(1). 44–53. 5 indexed citations

14.

Benner, Joshua S., Leif Erhardt, Zbigniew Gaciong, et al.. (2007). Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials. 28(5). 662–673. 10 indexed citations

15.

Winkelmayer, Wolfgang C., Joshua S. Benner, Robert J. Glynn, et al.. (2006). Assessing Health State Utilities in Elderly Patients at Cardiovascular Risk. Medical Decision Making. 26(3). 247–254. 9 indexed citations

16.

Benner, Joshua S., Timothy W. Smith, David Klingman, et al.. (2005). Cost-Effectiveness of Rosuvastatin Compared with Other Statins from a Managed Care Perspective. Value in Health. 8(6). 618–628. 17 indexed citations

17.

Petrilla, Allison, Joshua S. Benner, David Battleman, Jonothan C. Tierce, & Elisabeth Hazard. (2005). Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications. International Journal of Clinical Practice. 59(12). 1441–1451. 67 indexed citations

18.

Benner, Joshua S., Michael Pollack, Timothy W. Smith, et al.. (2005). Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. American Journal of Health-System Pharmacy. 62(14). 1468–1475. 57 indexed citations

19.

Benner, Joshua S., Jonothan C. Tierce, Christie M. Ballantyne, et al.. (2004). Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. PharmacoEconomics. 22(S3). 13–23. 90 indexed citations

20.

Wang, Philip S., Joshua S. Benner, Robert J. Glynn, et al.. (2003). How well do patients report noncompliance with antihypertensive medications?: a comparison of self‐report versus filled prescriptions. Pharmacoepidemiology and Drug Safety. 13(1). 11–19. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact